Join the Afluria Quadrivalent group to help and get support from people like you.
Afluria Quadrivalent News (Page 3)
IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race
FRIDAY, Oct. 18, 2024 – Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social...
The Right Time is Now to Get Your Flu Vaccine
THURSDAY, Oct. 17, 2024 – Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug Administration says. The ideal time to get the...
Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases
FRIDAY, Oct. 11, 2024 – For patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual care, according to a...
This Season's Flu Vaccine Cuts Risk of Hospitalization by Almost 35%
THURSDAY, Oct. 3, 2024, HealthDay News – The Southern Hemisphere's flu season is winding down, and new data shows this year's flu shot was 34.5% effective in keeping folks there who got influenza...
FDA Approves First Flu Vaccine That Can Be Self-Administered at Home
FRIDAY, Sept. 20, 2024 – On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a "new option for receiving a safe and effective...
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...